Cover Image

Phase II dose escalation study of caspofungin for invasive aspergillosis

Saved in:
Bibliographic Details
Main Authors: Cornely, Oliver Andreas (Author) , Vehreschild, J. J. (Author) , Vehreschild, M. J. G. T. (Author) , Würthwein, G. (Author) , Arenz, D. (Author) , Schwartz, S. (Author) , Heußel, Claus Peter (Author) , Silling, G. (Author) , Mahne, M. (Author) , Franklin, J. (Author) , Harnischmacher, U. (Author) , Wilkens, A. (Author) , Farowski, F. (Author) , Karthaus, M. (Author) , Lehrnbecher, T. (Author) , Ullmann, A. J. (Author) , Hallek, M. (Author) , Groll, A. H. (Author)
Format: Article (Journal)
Language:English
Published: 2011
In: Antimicrobial agents and chemotherapy
Year: 2011, Volume: 55, Issue: 12, Pages: 5798-5803
ISSN:1098-6596
DOI:10.1128/AAC.05134-11
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1128/AAC.05134-11
Verlag, lizenzpflichtig, Volltext: https://journals.asm.org/doi/epub/10.1128/AAC.05134-11
Get full text
Author Notes:O.A. Cornely, J.J. Vehreschild, M.J.G.T. Vehreschild, G. Würthwein, D. Arenz, S. Schwartz, C.P. Heussel, G. Silling, M. Mahne, J. Franklin, U. Harnischmacher, A. Wilkens, F. Farowski, M. Karthaus, T. Lehrnbecher, A.J. Ullmann, M. Hallek, and A.H. Groll

MARC

LEADER 00000caa a2200000 c 4500
001 1799542122
003 DE-627
005 20220820165117.0
007 cr uuu---uuuuu
008 220413s2011 xx |||||o 00| ||eng c
024 7 |a 10.1128/AAC.05134-11  |2 doi 
035 |a (DE-627)1799542122 
035 |a (DE-599)KXP1799542122 
035 |a (OCoLC)1341458911 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Cornely, Oliver Andreas  |d 1967-  |e VerfasserIn  |0 (DE-588)121712915  |0 (DE-627)081485123  |0 (DE-576)292844425  |4 aut 
245 1 0 |a Phase II dose escalation study of caspofungin for invasive aspergillosis  |c O.A. Cornely, J.J. Vehreschild, M.J.G.T. Vehreschild, G. Würthwein, D. Arenz, S. Schwartz, C.P. Heussel, G. Silling, M. Mahne, J. Franklin, U. Harnischmacher, A. Wilkens, F. Farowski, M. Karthaus, T. Lehrnbecher, A.J. Ullmann, M. Hallek, and A.H. Groll 
246 3 3 |a Phase II dose escalation study of caspofungin for invasive aspergillosis 
264 1 |c 2011 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published ahead of print on 12 September 2011 
500 |a Im Titel ist die "2" als römische Zahl dargestellt 
500 |a Gesehen am 13.04.2022 
700 1 |a Vehreschild, J. J.  |e VerfasserIn  |4 aut 
700 1 |a Vehreschild, M. J. G. T.  |e VerfasserIn  |4 aut 
700 1 |a Würthwein, G.  |e VerfasserIn  |4 aut 
700 1 |a Arenz, D.  |e VerfasserIn  |4 aut 
700 1 |a Schwartz, S.  |e VerfasserIn  |4 aut 
700 1 |a Heußel, Claus Peter  |e VerfasserIn  |0 (DE-588)1048631389  |0 (DE-627)780769422  |0 (DE-576)40288146X  |4 aut 
700 1 |a Silling, G.  |e VerfasserIn  |4 aut 
700 1 |a Mahne, M.  |e VerfasserIn  |4 aut 
700 1 |a Franklin, J.  |e VerfasserIn  |4 aut 
700 1 |a Harnischmacher, U.  |e VerfasserIn  |4 aut 
700 1 |a Wilkens, A.  |e VerfasserIn  |4 aut 
700 1 |a Farowski, F.  |e VerfasserIn  |4 aut 
700 1 |a Karthaus, M.  |e VerfasserIn  |4 aut 
700 1 |a Lehrnbecher, T.  |e VerfasserIn  |4 aut 
700 1 |a Ullmann, A. J.  |e VerfasserIn  |4 aut 
700 1 |a Hallek, M.  |e VerfasserIn  |4 aut 
700 1 |a Groll, A. H.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Antimicrobial agents and chemotherapy  |d Washington, DC : Soc., 1972  |g 55(2011), 12 vom: Dez., Seite 5798-5803  |h Online-Ressource  |w (DE-627)306316919  |w (DE-600)1496156-8  |w (DE-576)09718859X  |x 1098-6596  |7 nnas  |a Phase II dose escalation study of caspofungin for invasive aspergillosis 
773 1 8 |g volume:55  |g year:2011  |g number:12  |g month:12  |g pages:5798-5803  |g extent:6  |a Phase II dose escalation study of caspofungin for invasive aspergillosis 
856 4 0 |u https://doi.org/10.1128/AAC.05134-11  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.asm.org/doi/epub/10.1128/AAC.05134-11  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220413 
993 |a Article 
994 |a 2011 
998 |g 1048631389  |a Heußel, Claus Peter  |m 1048631389:Heußel, Claus Peter  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PH1048631389  |e 950000PH1048631389  |e 950900PH1048631389  |e 50000PH1048631389  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 7 
999 |a KXP-PPN1799542122  |e 411730710X 
BIB |a Y 
SER |a journal 
JSO |a {"title":[{"title":"Phase II dose escalation study of caspofungin for invasive aspergillosis","title_sort":"Phase II dose escalation study of caspofungin for invasive aspergillosis"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Published ahead of print on 12 September 2011","Im Titel ist die \"2\" als römische Zahl dargestellt","Gesehen am 13.04.2022"],"origin":[{"dateIssuedDisp":"2011","dateIssuedKey":"2011"}],"relHost":[{"origin":[{"dateIssuedKey":"1972","dateIssuedDisp":"1972-","publisherPlace":"Washington, DC","publisher":"Soc."}],"title":[{"subtitle":"AAC","title":"Antimicrobial agents and chemotherapy","title_sort":"Antimicrobial agents and chemotherapy"}],"note":["Gesehen am 09.06.21"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"recId":"306316919","physDesc":[{"extent":"Online-Ressource"}],"disp":"Phase II dose escalation study of caspofungin for invasive aspergillosisAntimicrobial agents and chemotherapy","titleAlt":[{"title":"AAC"}],"pubHistory":["1.1972 -"],"name":{"displayForm":["publ. by the American Society for Microbiology"]},"corporate":[{"role":"isb","display":"American Society for Microbiology"}],"part":{"issue":"12","text":"55(2011), 12 vom: Dez., Seite 5798-5803","extent":"6","pages":"5798-5803","volume":"55","year":"2011"},"id":{"zdb":["1496156-8"],"eki":["306316919"],"issn":["1098-6596"]}}],"person":[{"display":"Cornely, Oliver Andreas","given":"Oliver Andreas","role":"aut","family":"Cornely"},{"display":"Vehreschild, J. J.","role":"aut","given":"J. J.","family":"Vehreschild"},{"role":"aut","given":"M. J. G. T.","family":"Vehreschild","display":"Vehreschild, M. J. G. T."},{"display":"Würthwein, G.","family":"Würthwein","given":"G.","role":"aut"},{"display":"Arenz, D.","given":"D.","role":"aut","family":"Arenz"},{"given":"S.","role":"aut","family":"Schwartz","display":"Schwartz, S."},{"family":"Heußel","given":"Claus Peter","role":"aut","display":"Heußel, Claus Peter"},{"display":"Silling, G.","given":"G.","role":"aut","family":"Silling"},{"display":"Mahne, M.","family":"Mahne","role":"aut","given":"M."},{"display":"Franklin, J.","role":"aut","given":"J.","family":"Franklin"},{"display":"Harnischmacher, U.","role":"aut","given":"U.","family":"Harnischmacher"},{"role":"aut","given":"A.","family":"Wilkens","display":"Wilkens, A."},{"display":"Farowski, F.","given":"F.","role":"aut","family":"Farowski"},{"display":"Karthaus, M.","role":"aut","given":"M.","family":"Karthaus"},{"display":"Lehrnbecher, T.","given":"T.","role":"aut","family":"Lehrnbecher"},{"display":"Ullmann, A. J.","family":"Ullmann","role":"aut","given":"A. J."},{"display":"Hallek, M.","role":"aut","given":"M.","family":"Hallek"},{"display":"Groll, A. H.","family":"Groll","given":"A. H.","role":"aut"}],"recId":"1799542122","physDesc":[{"extent":"6 S."}],"id":{"doi":["10.1128/AAC.05134-11"],"eki":["1799542122"]},"name":{"displayForm":["O.A. Cornely, J.J. Vehreschild, M.J.G.T. Vehreschild, G. Würthwein, D. Arenz, S. Schwartz, C.P. Heussel, G. Silling, M. Mahne, J. Franklin, U. Harnischmacher, A. Wilkens, F. Farowski, M. Karthaus, T. Lehrnbecher, A.J. Ullmann, M. Hallek, and A.H. Groll"]},"titleAlt":[{"title":"Phase II dose escalation study of caspofungin for invasive aspergillosis"}]} 
SRT |a CORNELYOLIPHASEIIDOS2011 

Similar Items